Target intelligence / Profile preview

Plasma membrane lipid bilayer in acidic microenvironment

Molecular classification
Lipid bilayer, Cellular structure, Other
01

Overview

The plasma membrane lipid bilayer in an acidic microenvironment is a physiological target utilized for the selective delivery of therapeutic and diagnostic agents. In many pathological conditions, most notably solid tumors, the extracellular environment becomes acidic (pH 6.0–6.8) due to the Warburg effect, where cancer cells favor glycolysis over oxidative phosphorylation, leading to lactic acid accumulation (Gatenby & Gillies, 2004 [1]). This localized acidity distinguishes the diseased tissue from healthy tissue, which maintains a physiological pH of approximately 7.4. Drugs designed for this target, such as pH-Low Insertion Peptides (pHLIPs), exploit this pH gradient; at neutral pH, these peptides are unstructured and reside on the membrane surface, but upon protonation in an acidic environment, they form an alpha-helix that inserts across the lipid bilayer (Reshetnyak et al., 2006 [2]). This mechanism allows for the direct translocation of membrane-impermeable molecules, such as toxins or imaging dyes, into the cytoplasm or their tethering to the cell surface (Andreev et al., 2014 [3]). Beyond oncology, this target is relevant in treating inflammation and ischemia, where metabolic stress similarly lowers local pH (Liu et al., 2013 [4]). By targeting the physical state of the membrane in these specific environments, researchers can achieve high therapeutic indices and reduced systemic toxicity.

Other names
Acidic tumor microenvironment lipid bilayerpH-sensitive membraneAcidic cell surfaceTME lipid bilayer
02

Mechanism of action

pH-dependent transmembrane insertion and cargo delivery

03

Biological functions

Cellular barrierMembrane transportIon homeostasispH regulation
04

Disease associations

CancerInflammationIschemiaStroke
05

Safety considerations

Off-target insertion in acidic healthy tissues (e.g., kidney, stomach)Potential for systemic acidosis to trigger premature drug releaseVariability in tumor pH levels
06

Interacting drugs

pHLIP-MT1 (VMT-01)

4 more in the full profile.

07

Biomarkers

Extracellular pH (pHe)Lactic acid concentrationCarbonic anhydrase IX (CAIX) expression

Beyond the preview

Go deeper on Plasma membrane lipid bilayer in acidic microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma membrane lipid bilayer in acidic microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call